FDA-2025-N-6895 for Pharmacy Compounding Advisory Committee
By promoting weight loss and improving insulin sensitivity, Semaglutide helps prevent fat buildup in the liver
Figure 1 plots the number of semaglutide manufacturers requesting NDC codes for semaglutide powder, all organized by the date of the first NDC request
Patients with uncontrolled hyperthyroidism may experience amplified heart-rate elevation from GLP-1 therapy, while those with untreated hypothyroidism might see slower weight loss progress despite appropriate medication dosing
CJC-1295 mimics this natural signal
Patients have reported the following side effects when taking this medication: Vision loss Acute kidney injury Hypoglycemia or dangerously low blood sugar Liver or kidney failure Suicidal thoughts Excessive vomiting Gastroparesis or stomach paralysis Gastric/bowel obstruction Ileus (intestinal blockage) Pseudo intestinal obstruction Pancreatitis Biliary diseases Warning Signs of Gastroparesis/Stomach Paralysis One of the most severe complications affecting Ozempic, Wegovy, Rybelsus, Mounjaro, and Trulicity patients is gastroparesis